Adults | |||
Enrolled in 2003–11 | Enrolled in 2012–15 | ||
CD4 lymphocyte count of < 200 cells/ μl irrespective of WHO clinical stage at the time of first presentation to the HIV care | CD4 lymphocyte count of < 350 cells/ μl irrespective of WHO clinical stage at the time of first presentation to the HIV care | ||
WHO clinical stage 3 or 4 irrespective of CD4 count at the time of first presentation to the HIV care b | WHO clinical stage 3 or 4 irrespective of CD4 count at the time of first presentation to the HIV care | ||
Childrenc | Late presentation for HIV care [70] | ||
Moderate immune-suppression (damage) if CD4 count between | Severe immune-suppression (damage) if CD4 count between | ||
0–12 months | 750–1500 cells/ μl | < 750 cells/ μl | |
1–5 years | 500–1000 cells/ μl | < 500 cells/ μl | |
≥ 6 years | 200–500 cells/ μl (enrolled in 2003–2011) | < 200 cells/ μl (enrolled in 2003–11) | |
≥ 6 years | 350–500 cells/ μl (enrolled in 2012–2015) | < 350 cells/ μl (enrolled in 2012–2015) |